Key Finding:
Sarcoma subtypes previously demonstrated as immune checkpoint inhibitor responsive have high T cell inflamed score (TIS), suggesting other sarcomas with high TIS may be responsive as well.
– Caris Life Sciences
Key Finding:
Sarcoma subtypes previously demonstrated as immune checkpoint inhibitor responsive have high T cell inflamed score (TIS), suggesting other sarcomas with high TIS may be responsive as well.